Table 1. Non-ocular baseline characteristics by study arm.
| Fixed dosing | PRN dosing | |
|---|---|---|
| Males, n (%) (N) | 40 (80) (50) | 34 (68) (50) |
| Age (years), mean (SD) (N) | 63.8 (11.1) (50) | 65.4 (9.8) (50) |
| Ethnicity (N) | (50) | (50) |
| White/Caucasian, n (%) | 34 (68) | 35 (70) |
| Black or African, n (%) | 5 (10) | 5 (10) |
| South Asian, n (%) | 10 (20) | 8 (16) |
| Other, n (%) | 1 (2) | 2 (4) |
| Diabetes (N) | (50) | (50) |
| Type 1, n (%) | 7(14) | 2 (4) |
| Type 2 on insulin, n (%) | 22 (44) | 22 (44) |
| Type 2 on tablets, n (%) | 21 (42) | 26 (52) |
| Duration of diabetes (months), median (IQR) (N) | 192 (112, 255) (50) | 196 (124, 249) (50) |
| HbA1c (%), mean (SD) (N) | 8.1 (1.4) (50) | 7.7 (1.3) (50) |
| Systolic BP (mm Hg), mean (SD) (N) | 148.5 (20.5) (50) | 142.8 (20.5) (50) |
| Diastolic BP (mm Hg), mean (SD) (N) | 79.3 (9.8) (50) | 77.7 (10.8) (50) |
Abbreviations: BP, blood pressure; HbA1c, glycated haemoglobin; IQR, interquartile range; n, number of patients; N, total number of patients; PRN, pro-re-nata.